Status:
TERMINATED
Global CALM Implementation Study
Lead Sponsor:
University Health Network, Toronto
Conditions:
Depression
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to evaluate the implementation of the Managing Cancer and Living Meaningfully (CALM) Program in diverse cultural settings, including its feasibility, fidelity, and acceptability. It w...
Detailed Description
CALM is a semi-structured, manualized, individual psychotherapy designed for patients with advanced cancer and their loved ones. Research conducted over the past decade has shown that CALM is a feasib...
Eligibility Criteria
Inclusion
- The research team will approach clinicians who:
- have expressed interest in taking part in the Global CALM Program;
- able to deliver psychotherapeutic care according to the legislation/organizational policy that regulates their profession;
- ≥18 years of age;
- able to provide informed consent;
- fluent in English (or other language(s) in which training and supervision will be offered);
- fluent in the main language spoken in the country where their centre is located (to be able to deliver CALM sessions); and
- willing/able to engage with training in the CALM therapy and attend in-person or online supervision meetings (based on feasibility).
Exclusion
- \-
Key Trial Info
Start Date :
June 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04499690
Start Date
June 17 2019
End Date
December 23 2022
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9